Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

Granulocyte-colony stimulating factors as adjunctive therapy for diabetic foot infections.

Cruciani M, Lipsky BA, Mengoli C, de Lalla F.

Cochrane Database Syst Rev. 2013 Aug 17;(8):CD006810. doi: 10.1002/14651858.CD006810.pub3. Review.

PMID:
23955465
2.

Antimicrobial prophylaxis in colorectal surgery: focus on ertapenem.

de Lalla F.

Ther Clin Risk Manag. 2009;5:829-39. Epub 2009 Nov 2.

3.

Granulocyte-colony stimulating factors as adjunctive therapy for diabetic foot infections.

Cruciani M, Lipsky BA, Mengoli C, de Lalla F.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD006810. doi: 10.1002/14651858.CD006810.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;8:CD006810.

PMID:
19588405
4.

Outpatient parenteral antibiotic therapy in the elderly: an Italian observational multicenter study.

Esposito S, Leone S, Noviello S, Ianniello F, Russo M, Foti G, Carpentieri MS, Cellesi C, Zanelli G, Cellini A, Girmenia C, De Lalla F, Maiello A, Maio P, Acone N, Marranconi F, Sabbatani S, Pantaleoni M, Ghinelli F, Soranzo ML, Viganò P, Re T, Viale P, Scudeller L; Registro Nazionale OPAT.

J Chemother. 2009 Apr;21(2):193-8.

PMID:
19423473
5.

Clinical features of bacterial meningitis in Italy: a multicenter prospective observational study.

Lazzarini L, Toti M, Fabris P, Conti E, Magni G, Mazzotta F, De Lalla F; Mentore Study Group Clinical Investigators.

J Chemother. 2008 Aug;20(4):478-87.

PMID:
18676229
6.

Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction.

Data Collection on Adverse Events of Anti-HIV Drugs Study Group, Sabin CA, d'Arminio Monforte A, Friis-Moller N, Weber R, El-Sadr WM, Reiss P, Kirk O, Mercie P, Law MG, De Wit S, Pradier C, Phillips AN, Lundgren JD.

Clin Infect Dis. 2008 Apr 1;46(7):1101-10. doi: 10.1086/528862.

7.

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration.

D:A:D Study Group, Sabin CA, Worm SW, Weber R, Reiss P, El-Sadr W, Dabis F, De Wit S, Law M, D'Arminio Monforte A, Friis-Møller N, Kirk O, Pradier C, Weller I, Phillips AN, Lundgren JD.

Lancet. 2008 Apr 26;371(9622):1417-26. doi: 10.1016/S0140-6736(08)60423-7. Epub 2008 Apr 2. Erratum in: Lancet. 2008 Jul 26;372(9635):292.

8.

Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): analysis of the incidence of newly acquired hepatitis B infection and syphilis.

Cicconi P, Cozzi-lepri A, Orlando G, Matteelli A, Girardi E, Degli Esposti A, Moioli C, Rizzardini G, Chiodera A, Ballardini G, Tincati C, d'Arminio Monforte A; I.Co.N.A. Study Group.

Infection. 2008 Feb;36(1):46-53. doi: 10.1007/s15010-007-6300-z. Epub 2008 Jan 29.

PMID:
18231722
9.

Outpatient parenteral antibiotic therapy for bone and joint infections: an italian multicenter study.

Esposito S, Leone S, Noviello S, Ianniello F, Fiore M, Russo M, Foti G, Carpentieri MS, Cellesi C, Zanelli G, Cellini A, Girmenia C, De Lalla F, Maiello A, Maio P, Marranconi F, Sabbatani S, Pantaleoni M, Ghinelli F, Soranzo ML, Vigano P, Re T, Viale P, Scudeller L, Scaglione F, Vullo V.

J Chemother. 2007 Aug;19(4):417-22.

PMID:
17855186
10.

Perioperative antibiotic prophylaxis: a critical review.

De Lalla F.

Surg Infect (Larchmt). 2006;7 Suppl 2:S37-9. Review.

PMID:
16895502
11.

Association between Enterococcus bacteraemia and death in neutropenic patients with haematological malignancies.

Todeschini G, Tecchio C, Borghero C, D'Emilio A, Pegoraro E, de Lalla F, Benedetti P, Spolaore P, Pellizzer G.

J Infect. 2006 Oct;53(4):266-73. Epub 2006 Jan 4.

PMID:
16388852
12.

Human leptospirosis in the Vicenza area (Italy) from 1990 to 2003: an epidemiological and clinical study.

Conti E, Lazzarini L, Reatto P, Tositti G, de Lalla F.

Infez Med. 2005 Dec;13(4):235-40.

13.

Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital.

Lazzarini L, Conti E, Tositti G, de Lalla F.

J Infect. 2005 Dec;51(5):383-9.

PMID:
16321649
14.

Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: a systematic review and meta-analysis.

Cruciani M, de Lalla F, Mengoli C.

Intensive Care Med. 2005 Nov;31(11):1479-87. Epub 2005 Sep 20. Review.

PMID:
16172847
15.

Impact of liver steatosis on virological response in [corrected] Italian patients with chronic hepatitis C treated with peg-interferon alpha-2b plus ribavarin.

Fabris P, Floreani A, Carlotto A, Baldo V, Bozzola L, Giordani MT, Negro F, Rassu M, Tramarin A, de Lalla F.

Aliment Pharmacol Ther. 2005 May 1;21(9):1173-8. Erratum in: Aliment Pharmacol Ther. 2005 Jun 1;21(11):1397.

16.

Are granulocyte colony-stimulating factors beneficial in treating diabetic foot infections?: A meta-analysis.

Cruciani M, Lipsky BA, Mengoli C, de Lalla F.

Diabetes Care. 2005 Feb;28(2):454-60.

PMID:
15677817
17.

Chlamydia pneumoniae infection in HIV-positive patients: prevalence and relationship with lipid profile.

Tositti G, Rassu M, Fabris P, Giordani M, Cazzavillan S, Reatto P, Zoppelletto M, Bonoldi M, Baldo V, Manfrin V, de Lalla F.

HIV Med. 2005 Jan;6(1):27-32.

18.

Alcohol is an important co-factor for both steatosis and fibrosis in Northern Italian patients with chronic hepatitis C.

Fabris P, Floreani A, Carlotto A, Giordani MT, Baldo V, Stecca C, Marchioro L, Tramarin A, Bertin T, Negro F, de Lalla F.

J Hepatol. 2004 Oct;41(4):644-51.

PMID:
15464246
19.

Therapy of chronic hepatitis C virus infection in HIV co-infected people.

Fabris P, Barnes E, Tositti G, Giordani MT, Grasso A, De Lalla F.

Curr Pharm Des. 2004;10(17):2111-22. Review.

PMID:
15279550
20.

Diagnosing and treating diabetic foot infections.

Lipsky BA, Berendt AR, Embil J, De Lalla F.

Diabetes Metab Res Rev. 2004 May-Jun;20 Suppl 1:S56-64. Review.

PMID:
15150816
21.

Prophylaxis with cefazolin plus clindamycin in clean-contaminated maxillofacial surgery.

Lazzarini L, Brunello M, Padula E, de Lalla F.

J Oral Maxillofac Surg. 2004 May;62(5):567-70.

PMID:
15122561
22.

Clostridial orthopedic infections: case reports and review of the literature.

Lazzarini L, Conti E, Ditri L, Turi G, de Lalla F.

J Chemother. 2004 Feb;16(1):94-7.

PMID:
15078006
23.

Candidal prosthetic hip infection in a patient with previous candidal septic arthritis.

Lazzarini L, Manfrin V, De Lalla F.

J Arthroplasty. 2004 Feb;19(2):248-52.

PMID:
14973873
24.

Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C.

Fabris P, Brown D, Tositti G, Bozzola L, Giordani MT, Bevilacqua P, de Lalla F, Webster GJ, Dusheiko G.

J Clin Virol. 2004 Mar;29(3):160-6.

PMID:
14962784
25.

A multicentre study of patient survival, disability, quality of life and cost of care: among patients with AIDS in northern Italy.

Tramarin A, Campostrini S, Postma MJ, Calleri G, Tolley K, Parise N, de Lalla F; Palladio Study Group.

Pharmacoeconomics. 2004;22(1):43-53.

PMID:
14720081
26.

Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy.

Fabris P, Floreani A, Tositti G, Vergani D, De Lalla F, Betterle C.

Aliment Pharmacol Ther. 2003 Sep 15;18(6):549-58. Review.

27.

Failure of intravenous linezolid to treat Clostridium difficile associated diarrhea.

Lazzarini L, De Lalla F.

J Chemother. 2003 Jun;15(3):299-300. No abstract available.

PMID:
12868561
28.

[Antimicrobial prophylaxis in clean surgery].

de Lalla F.

Infez Med. 1997 Dec;5(4):214-29. Italian.

29.

Occult hepatitis B virus infection in HIV/hepatitis C virus co-infected patients.

Fabris P, Giordani MT, Tositti G, Rassu M, De Lalla F.

AIDS. 2003 Jul 4;17(10):1581-2. No abstract available.

PMID:
12824807
30.

Regional and systemic prophylaxis with teicoplanin in total knee arthroplasty: a tissue penetration study.

Lazzarini L, Novelli A, Marzano N, Timillero L, Fallani S, Viola R, de Lalla F.

J Arthroplasty. 2003 Apr;18(3):342-6.

PMID:
12728428
31.

[Setting priorities in the prevention and control of nosocomial infections: an economic perspective]

Tramarin A, Bragagnolo L, Scagnelli M, De Lalla F.

Infez Med. 2000;1(8):7-17. Italian.

32.

[Outpatient Parenteral Antibiotic Therapy (OPAT): the Italian registry].

Esposito S, Ianniello F, Noviello S, Leone S, Ascione T, Tice A, Maiello A, de Lalla F, Girmenia C, Marranconi F, Serrentino G, Iaccarino A, Di Cianni E.

Infez Med. 2002 Sep;10(3):169-75. Italian.

33.

[Antibiotic prophylaxis in surgery: news and controversies].

Esposito S, Novelli A, de Lalla F.

Infez Med. 2002 Sep;10(3):131-44. Review. Italian.

34.

Outpatient therapy for febrile neutropenia: clinical and economic implications.

de Lalla F.

Pharmacoeconomics. 2003;21(6):397-413. Review.

PMID:
12678567
35.

Prevalence and clinical significance of circulating cryoglobulins in HIV-positive patients with and without co-infection with hepatitis C virus.

Fabris P, Tositti G, Giordani MT, Romanò L, Betterle C, Pignattari E, Tagliaferri C, Muratori P, Manfrin V, de Lalla F.

J Med Virol. 2003 Mar;69(3):339-43.

PMID:
12526043
36.

Successfull response to alpha 2b interferon plus ribavirin associated with venesectomies in a patient with chronic hepatitis C and genetic hemochromatosis.

Fabris P, Tositti G, Giordani MT, De Lalla F.

J Gastroenterol Hepatol. 2003 Jan;18(1):116-7. No abstract available.

PMID:
12519239
37.

Waterborne infections in the era of bioterrorism.

Tramarin A, Fabris P, Bishai D, Selle V, De Lalla F.

Lancet. 2002 Nov 23;360(9346):1699. No abstract available.

PMID:
12457828
38.

Long Bone Osteomyelitis.

Lazzarini L, De Lalla F, Mader JT.

Curr Infect Dis Rep. 2002 Oct;4(5):439-445.

PMID:
12228032
39.

The application of cost effectiveness analysis to derive a formulary for urinary tract infections.

Tramarin A, Bragagnolo L, Tolley K, Sartorelli S, Tositti G, Lazzarini L, Scagnelli M, Gallo R, Postma MJ, de Lalla F.

J Chemother. 2002 Apr;14(2):166-74.

PMID:
12017372
40.

Surgical prophylaxis in practice.

de Lalla F.

J Hosp Infect. 2002 Jan;50 Suppl A:S9-12. Review.

PMID:
11993642
41.

Antibiotic prophylaxis in orthopedic prosthetic surgery.

de Lalla F.

J Chemother. 2001 Nov;13 Spec No 1(1):48-53. Review.

PMID:
11936379
42.

Serum pepsinogen and gastrin levels in HIV-positive patients: relationship with CD4+ cell count and Helicobacter pylori infection.

Fabris P, Pilotto A, Bozzola L, Tositti G, Soffiati G, Manfrin V, de Lalla F.

Aliment Pharmacol Ther. 2002 Apr;16(4):807-11.

43.

Three-times weekly teicoplanin in the outpatient treatment of acute methicillin-resistant staphylococcal osteomyelitis: a pilot study.

Lazzarini L, Tramarin A, Bragagnolo L, Tositti G, Manfrin V, de LF.

J Chemother. 2002 Feb;14(1):71-5.

PMID:
11892903
44.

Maintenance therapy for cryptococcosis in patients with AIDS after successful primary therapy: oral fluconazole (300 mg daily) versus oral itraconazole (300 mg daily).

de Lalla F, Pellizzer G, Manfrin V, Benedetti P, Franzetti M, Nicolin R, Vaglia A.

Clin Microbiol Infect. 1999 Sep;5(9):567-570. No abstract available.

45.

Epidemiological analysis of vancomycin-resistant enterococci in a large tertiary-care hospital in Northern Italy.

Scagnelli M, Pellizer G, de Lalla F, D'Emilio A, Rassu M, Bragagnolo L, Reatto P, Veneri G, Ligozzi M, Fontana R.

Eur J Clin Microbiol Infect Dis. 2001 Sep;20(9):609-16.

PMID:
11714041
46.

Deep tissue biopsy vs. superficial swab culture monitoring in the microbiological assessment of limb-threatening diabetic foot infection.

Pellizzer G, Strazzabosco M, Presi S, Furlan F, Lora L, Benedetti P, Bonato M, Erle G, de Lalla F.

Diabet Med. 2001 Oct;18(10):822-7.

PMID:
11678973
47.

Pancreatic hyperamylasemia during acute gastroenteritis: incidence and clinical relevance.

Tositti G, Fabris P, Barnes E, Furlan F, Franzetti M, Stecca C, Pignattari E, Pesavento V, de Lalla F.

BMC Infect Dis. 2001;1:18. Epub 2001 Sep 27.

48.

Oral cephalosporins in airway infections.

de Lalla F.

Clin Microbiol Infect. 2000;6 Suppl 3:70-2. Review. No abstract available.

49.

[Antibiotic chemoprophylaxis in orthopedic prosthesis implantation].

de Lalla F.

J Chemother. 2000 Jul;12 Suppl 2:23-7. Italian.

PMID:
11428097
50.

Antibiotic therapy in acute renal failure.

Benedetti P, de Lalla F.

Contrib Nephrol. 2001;(132):136-45. Review. No abstract available.

PMID:
11395883

Supplemental Content

Loading ...
Support Center